US EditionPrevencio granted patents to protect proprietary coronary artery disease blood test platform - Cardiovascular News
Summary by Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Prevencio granted patents to protect proprietary coronary artery disease blood test platform - Cardiovascular News
Prevencio has been granted patents for its HART CADhs test in the USA—the second US patent for this novel test—as well as the EU and Japan. The patents protect Prevencio’s proprietary methods and algorithms for detecting obstructive coronary artery disease (CAD) using a multi-protein, artificial intelligence (AI)-driven blood test platform. The newly issued patents strengthen Prevencio’s intellectual property portfolio and support its long-term …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
